Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BWAY Brainsway	$12.70 +4.2%	$11.98	$7.06 ▼ $13.65	$240.01M	1.42	52,205 shs	190,534 shs
CVRX CVRx	$7.72 +2.8%	$6.93	$4.30 ▼ $18.55	$201.88M	1.27	325,725 shs	197,150 shs
SMTI Sanara MedTech	$31.92 +16.2%	$27.58	$23.53 ▼ $39.08	$283.71M	1.26	33,571 shs	86,618 shs
SURG SurgePays	$2.88 -1.0%	$2.93	$1.05 ▼ $3.47	$58.78M	0.44	750,006 shs	256,192 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BWAY Brainsway	+0.74%	+2.70%	-0.97%	+18.70%	+77.96%
CVRX CVRx	0.00%	+10.44%	+9.96%	+41.97%	-10.60%
SMTI Sanara MedTech	+2.27%	+12.03%	-5.47%	-12.24%	-1.29%
SURG SurgePays	0.00%	-0.68%	-7.32%	+15.02%	+9.81%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BWAY Brainsway	3.2911 of 5 stars	2.5	5.0	3.9	0.8	1.9
CVRX CVRx	2.7796 of 5 stars	3.4	1.0	2.4	4.2	0.6
SMTI Sanara MedTech	2.1015 of 5 stars	3.5	1.0	2.4	1.7	0.6
SURG SurgePays	3.4412 of 5 stars	3.5	5.0	3.1	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BWAY Brainsway	3.00	Buy	$14.25	12.20% Upside
CVRX CVRx	2.86	Moderate Buy	$14.00	81.35% Upside
SMTI Sanara MedTech	3.00	Buy	$49.50	55.08% Upside
SURG SurgePays	3.00	Buy	$9.00	212.50% Upside

Current Analyst Ratings Breakdown

Latest SURG, BWAY, SMTI, and CVRX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/5/2025	CVRX CVRx	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$11.00
7/7/2025	CVRX CVRx	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/16/2025	SURG SurgePays	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$8.75 ➝ $9.00
6/9/2025	BWAY Brainsway	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$16.00
5/15/2025	SMTI Sanara MedTech	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$51.00 ➝ $53.00

(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BWAY Brainsway	$43.46M	5.52	$0.26 per share	48.52	$3.31 per share	3.84
CVRX CVRx	$51.29M	3.94	N/A	N/A	$2.22 per share	3.48
SMTI Sanara MedTech	$91.57M	3.10	N/A	N/A	$4.45 per share	7.17
SURG SurgePays	$60.88M	0.97	N/A	N/A	$0.76 per share	3.79

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BWAY Brainsway	$2.92M	$0.20	63.50	79.38	N/A	9.01%	7.35%	4.72%	8/13/2025 (Estimated)
CVRX CVRx	-$59.97M	-$2.10	N/A	N/A	N/A	-95.61%	-79.31%	-40.96%	N/A
SMTI Sanara MedTech	-$9.66M	-$1.34	N/A	N/A	N/A	-12.48%	-29.22%	-13.20%	8/13/2025 (Estimated)
SURG SurgePays	-$45.73M	-$2.79	N/A	N/A	N/A	-136.37%	-206.01%	-153.67%	8/13/2025 (Estimated)

Latest SURG, BWAY, SMTI, and CVRX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2025	Q2 2025	BWAY Brainsway	$0.07	$0.10	+$0.03	$0.10	$12.34 million	$12.63 million
8/13/2025	Q2 2025	SMTI Sanara MedTech	-$0.33	-$0.23	+$0.10	-$0.23	$25.15 million	$25.83 million
8/13/2025	Q2 2025	SURG SurgePays	-$0.31	-$0.36	-$0.05	-$0.36	$16.14 million	N/A
8/4/2025	Q2 2025	CVRX CVRx	-$0.52	-$0.57	-$0.05	-$0.57	$13.22 million	$13.59 million
5/14/2025	Q1 2025	SMTI Sanara MedTech	-$0.31	-$0.41	-$0.10	-$0.41	$23.48 million	$23.43 million
5/13/2025	Q1 2025	BWAY Brainsway	$0.02	$0.04	+$0.02	$0.04	$11.45 million	$11.54 million
5/13/2025	Q1 2025	SURG SurgePays	-$0.40	-$0.38	+$0.02	-$0.38	$9.80 million	$10.58 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BWAY Brainsway	N/A	N/A	N/A	N/A	N/A
CVRX CVRx	N/A	N/A	N/A	N/A	N/A
SMTI Sanara MedTech	N/A	N/A	N/A	N/A	N/A
SURG SurgePays	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BWAY Brainsway	N/A	5.03	4.75
CVRX CVRx	0.85	11.99	10.78
SMTI Sanara MedTech	1.18	2.77	2.54
SURG SurgePays	0.24	1.72	1.41

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BWAY Brainsway	30.11%
CVRX CVRx	75.27%
SMTI Sanara MedTech	8.10%
SURG SurgePays	6.94%

Insider Ownership

Company	Insider Ownership
BWAY Brainsway	19.00%
CVRX CVRx	18.90%
SMTI Sanara MedTech	42.60%
SURG SurgePays	30.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BWAY Brainsway	120	18.90 million	15.31 million	Not Optionable
CVRX CVRx	160	26.15 million	21.21 million	Optionable
SMTI Sanara MedTech	60	8.89 million	5.10 million	Not Optionable
SURG SurgePays	40	20.41 million	14.19 million	Optionable

SURG, BWAY, SMTI, and CVRX Headlines

Recent News About These Companies

SurgePays, Inc. (SURG) Reports Q2 Loss, Lags Revenue Estimates

2 hours ago | zacks.com

SurgePays Accelerates Growth Across All Business Verticals; Reports Q2 2025 Results and Issues Revenue Guidance of $75M to $90M in 2025 and $225M to $240M in 2026

4 hours ago | prnewswire.com

SurgePays (SURG) Projected to Post Earnings on Wednesday

August 11 at 2:49 AM | americanbankingnews.com

SurgePays (NASDAQ:SURG) Shares Pass Above Two Hundred Day Moving Average - What's Next?

August 10 at 4:57 AM | marketbeat.com

SurgePays (SURG) Expected to Announce Earnings on Tuesday

August 6, 2025 | marketbeat.com

SurgePays to Host Second Quarter 2025 Financial Results Conference Call on Wednesday, August 13

August 5, 2025 | prnewswire.com

SURG | SurgePays Inc. Annual Income Statement | MarketWatch

July 31, 2025 | marketwatch.com

SurgePays (NASDAQ:SURG) Share Price Passes Above 200-Day Moving Average - What's Next?

July 26, 2025 | marketbeat.com

SurgePays CEO Brian Cox to Participate in Fireside Chat Hosted by Water Tower Research

July 23, 2025 | prnewswire.com

SurgePays to Feature New "Phone-in-a-Box" Prepaid Service and ClearLine Point-of-Sale Marketing Platform at Upcoming All Wireless and Prepaid Expo

July 21, 2025 | prnewswire.com

SurgePays (NASDAQ:SURG) Stock Price Crosses Above Two Hundred Day Moving Average - Should You Sell?

July 18, 2025 | marketbeat.com

SurgePays Launches New PrePaid Service Smartphones Designed For Convenience Stores And Non-Wireless Retail Channels

July 3, 2025 | twice.comT

GPOPlus+ Shareholder Update

June 30, 2025 | accessnewswire.comA

SurgePays launches prepaid phone-in-a-box service for convenience stores

June 27, 2025 | investing.com

SurgePays Launches New Prepaid Service, "Phone-in-a-Box," Designed for Convenience Stores and Non-Wireless Retail Channels

June 26, 2025 | prnewswire.com

SurgePays to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference on June 24-25

June 11, 2025 | prnewswire.com

SurgePays Confirms Directors and Ratifies Accounting Firm

May 20, 2025 | tipranks.com

AT&T (NYSE:T) Partners With Carbyne For APEX Continuity Emergency Solution For PSAPs

May 20, 2025 | finance.yahoo.com

US$8.75 - That's What Analysts Think SurgePays, Inc. (NASDAQ:SURG) Is Worth After These Results

May 17, 2025 | uk.finance.yahoo.com

SurgePays Secures $7M Convertible Note for Expansion

May 16, 2025 | tipranks.com

Why SurgePays, Inc.’s (SURG) Stock Is Down 19.64%

May 15, 2025 | aaii.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SURG, BWAY, SMTI, and CVRX Company Descriptions

Brainsway NASDAQ:BWAY

$12.70 +0.51 (+4.18%)

Closing price 04:00 PM Eastern

Extended Trading

$13.22 +0.52 (+4.06%)

As of 07:47 PM Eastern

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

CVRx NASDAQ:CVRX

$7.72 +0.21 (+2.80%)

Closing price 04:00 PM Eastern

Extended Trading

$7.74 +0.02 (+0.19%)

As of 04:10 PM Eastern

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Sanara MedTech NASDAQ:SMTI

$31.92 +4.45 (+16.20%)

Closing price 04:00 PM Eastern

Extended Trading

$31.84 -0.08 (-0.25%)

As of 07:59 PM Eastern

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

SurgePays NASDAQ:SURG

$2.88 -0.03 (-1.03%)

Closing price 04:00 PM Eastern

Extended Trading

$2.82 -0.06 (-2.26%)

As of 07:59 PM Eastern

SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time